IRIS
DALMASSO, BRUNA SAMIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.675
Totale 1.675
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 1.675
Totale 1.675
Salva come PNG Salva come JPEG
Città #
Genova 1.095
Rapallo 363
Genoa 214
Bordighera 3
Totale 1.675
Salva come PNG Salva come JPEG
Nome #
Heterogeneity and frequency of BRAF mutations in primary melanoma: Comparison between molecular methods and immunohistochemistry 168
CDKN2A germline mutations are not associated with poor survival in an Italian cohort of melanoma patients 131
Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: Interplay between germline and somatic variations 124
Circulating MicroRNAs as easy-to-measure aging biomarkers in older breast cancer patients: Correlation with chronological age but not with fitness/frailty status 121
Age-related microRNAs in older breast cancer patients: Biomarker potential and evolution during adjuvant chemotherapy 114
An open pilot study of zonisamide augmentation in major depressive patients not responding to a low dose trial with duloxetine: Preliminary results on tolerability and clinical effects 106
The impact of adjuvant chemotherapy in older breast cancer patients on clinical and biological aging parameters 100
Biological ageing and frailty markers in breast cancer patients 95
Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide 93
Correction: Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: Interplay between germline and somatic variations [Oncotarget. 2018; 9:5691-5702]doi 10.18632/oncotarget.23204 81
Disruption of DNA damage response pathways in tumorigenesis: investigating the role of ATM and BAP1 in hereditary cancers. 77
Clinical, pathological and dermoscopic phenotype of MITF p.E318K carrier cutaneous melanoma patients 63
Insights into genetic susceptibility to melanoma by gene panel testing: Potential pathogenic variants in acd, atm, bap1, and pot1 60
Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI) 57
Evolution of approaches to identify melanoma missing heritability 48
Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia 42
Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications 35
Efficacy of braf and mek inhibition in patients with braf‐mutant advanced melanoma and germline cdkn2a pathogenic variants 35
Factors Affecting Sentinel Node Metastasis in Thin (T1) Cutaneous Melanomas: Development and External Validation of a Predictive Nomogram 34
Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility 34
Beyond BRCA: The Emerging Significance of DNA Damage Response and Personalized Treatment in Pancreatic and Prostate Cancer Patients 30
Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients 30
First international workshop of the ATM and cancer risk group (4-5 December 2019) 29
Predictors of germline status for hereditary melanoma: 5 years of multi-gene panel testing within the Italian Melanoma Intergroup 17
Reply to E. Hindié 17
Totale 1.741
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.053
article - articoli 6.838
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.891
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201988 0 0 0 0 0 0 0 0 0 0 48 40
2019/2020387 17 7 5 31 31 44 70 34 36 46 51 15
2020/2021225 13 13 13 17 9 31 7 18 23 32 29 20
2021/2022286 23 4 14 27 14 30 9 57 25 38 11 34
2022/2023422 38 44 8 46 67 50 0 42 69 2 48 8
2023/2024163 12 19 2 30 13 30 11 24 8 14 0 0
Totale 1.741